Urology update 2 - Management of uro-oncology and associated urological symptoms

Hong Kong Practitioner

Volumn 31, Issue 3, 2009, Pages 128-132

  Ng, Chi Fai ^a   Ng, Man Tat ^b   Yip, Sidney K H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NORTH DISTRICT HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLEEDING TENDENCY; CANCER GRADING; CANCER PATIENT; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CYSTITIS; DIGITAL RECTAL EXAMINATION; FALSE POSITIVE RESULT; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; IMMUNOASSAY; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY INFARCTION; KIDNEY INJURY; KIDNEY PAPILLA NECROSIS; KIDNEY POLYCYSTIC DISEASE; MALE; PATIENT COUNSELING; PROGNOSIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; RADIATION INJURY; REVIEW; SCROTAL SWELLING; SOLID TUMOR; TRANSITIONAL CELL CARCINOMA; URINARY TRACT INFECTION; UROLITHIASIS;

EID: 72849149791     PISSN: 10273948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Hong Kong Cancer Registry. http://www3.ha.org.hk/cancereg/eng/stat.asp.
2. Damber JE, Aus G. Prostate cancer. Lancet 2008;371(9625):1710-1721.
3. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997;29(2):95-120.
4. Kolonel LN, Altshuler D, Henderson BE. The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nature Reviews 2004; Cancer 4 s(7):519-527.
5. Reissigl A, Pointner J, Horninger W, et al. PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors. Prostate 1997;30(1):20-25. (Pubitemid 27053536)
6. Chu KC, Tarone RE, Freeman HP. Trends in prostate cancer mortality among black men and white men in the United States. Cancer 2003;97(6):1507-1516.
7. Oberaigner W, Horninger W, Klocker H, et al. Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing. Am J Epidemiol 2006;164(4):376-384. (Pubitemid 44297346)
8. Stamey TA, Caldwell M, McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 2004;172(4 Pt 1):1297-1301.
9. Raaijmakers R, Wildhagen MF, Ito K, et al. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam. Urology 2004;63(2):316-320. (Pubitemid 38234427)
10. Andriole GL, Levin DL, Crawford ED, et al. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 2005;97(6):433-438. (Pubitemid 40528606)
11. Matzkin H, Perito PE, Soloway MS. Prognostic factors in metastatic prostate cancer. Cancer 1993;72(12 Suppl):3788-3792. (Pubitemid 23361528)
12. Sakr WA, Haas GP, Cassin BF, et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993; 150(2 Pt 1):379-385. (Pubitemid 23215874)
13. Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet 2003;361(9366): 1359-1367.
14. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. NEJM 2004;350(22):2239-2246.
15. Carter HB. Prostate cancers in men with low PSA levels-must we find them? NEJM 2004;350(22):2292-2294.
16. Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98(18):1331-1334. (Pubitemid 44530728)
17. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 2002;167(1):57-60. (Pubitemid 34024497)
18. Cooperberg MR, Mallin K, Ritchey J, et al. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol 2008;179(6):2131-2135.
19. Borin JF. Laparoscopic radical nephrectomy: long-term outcomes. Curr Opin Urol 2008;18(2):139-144. (Pubitemid 351317380)
20. Eskicorapci SY, Teber D, Schulze M, et al. Laparoscopic Radical Nephrectomy: The New Gold Standard Surgical Treatment for Localized Renal Cell Carcinoma. TheScientificWorld JOURNAL 2007;7:825-836.
21. Fergany AF, Saad IR, Woo L, et al. Open partial nephrectomy for tumor in a solitary kidney: experience with 400 cases. J Urol 2006;175(5):1630-1633.
22. Bosniak MA. The current radiological approach to renal cysts. Radiology 1986;158(1):1-10.
23. Harland SJ, Cook PA, Fossa SD, et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group. J Urol 1998;160(4):1353-1357.
24. Jacobsen R, Bostofte E, Engholm G, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ 2000;321(7264): 789-792. (Pubitemid 30760377)
25. Dong C, Lonnstedt I, Hemminki K. Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur J Cancer 2001;37(15):1878-1885. (Pubitemid 32913316)
26. Forman D, Oliver RT, Brett AR, et al. Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer 1992;65(2):255-262.
27. Richie JP. Detection and treatment of testicular cancer. CA Cancer J Clin 1993;43(3):151-175.